Tuesday, March 26, 2024 10:59:41 PM
This is just from the Alcannist .. one of our companies!
MIGRAINE FORMULATION:
The global migraine drug market was valued at $6.7 billion in 2022 and is expected to swell to $10.9 billion by 2030.
With an estimated .009% introductory year market share in the migraine drug sector , we are forecasting $576,000.00 in sales for our CBD based migraine formulation (soon to be market released), which will be offered in multiple form factors, (vaporized, sublingual tinctures, transdermal patches, and gummies).
The Pain Management Market size is expected to grow from USD 75.41 billion in 2023 to USD 89.96 billion by 2028, at a CAGR of 3.59% during the forecast period (2023-2028).
Our pain management formula, (which will also be released in 5 different form factors), is ready for market. We project a .001% year one market capture worth $754,100.00 in gross sales.
The global Anxiety Disorders and Depression Treatment Market was valued at around US$ 11.2 billion in 2021. With a projected CAGR of 3.4% for the next ten years, the market is likely to reach a valuation of nearly US$ 16.1 billion by the end of 2032.
We estimate a .006% market share with an year one return worth $672,000.00 in sales which will also be released in 5 forms.
WITH A ROBUST PORTFOLIO OF PROPRIETARY FORMULATIONS TARGETING VARIOUS HEALTH CONCERNS, A COMMITMENT TO INNOVATION, AND A CENTRALIZED OPEN MARKET PLATFORM, THE ALCANNABIST STANDS AT THE FOREFRONT OF THE NATURAL WELLNESS INDUSTRY, POISED FOR SUBSTANTIAL GROWTH AND SUCCESS.
At Royal Biotek, our mission is to pioneer the advancement of biotechnology through cutting-edge alkaloid extraction, refinement, and synthesis, forging a path towards healthier lives and a more sustainable future. We are dedicated to harnessing the power of medicinal ethnobotany transforming traditional ecological knowledge into high-quality solutions that enhance well-being, promote innovation, and contribute to the well-being of humanity.
Our vision is to be a global leader in alkaloid extraction and refinement, recognized for our unwavering commitment to scientific excellence and sustainability. We strive to unlock the full potential of alkaloids, revolutionizing the pharmaceutical and agricultural industries. Meanwhile, we nurture a culture of innovation and environmental responsibility with all of our operations. Royal Biotek envisions a world where nature’s gifts are harnessed to address the mostpressing challenges of our time, creating a brighter and healthier future for all... “Natural solutions to national problems”
Over a year of research and development has led to the formation of several long term alkaloid supply contracts. We expect exponential revenue growth over the next 3-5 years as we roll out new products and capabilities.
We have also secured non-dilutive funding to support our current
operations with our sights set onexpansion.Wecurrentlyhave roughly $500,000 in inventory ready for distribution over the next1-2quarters,withmoreto come. We estimate that with our current, state of the art lab facilities and equipment we will have a potential yearly revenue between $550,000.00 and $2.75 Million.
This is DIRECTLY from their INVESTOR PRESENTATION November 2023 just for the ALCANNIST FYI!!
Partnerships::
Our Strategic acquisitions of The Alcannabist and Rocket Web Development and Design will allow us to develop more products and allow our marketing team to advertise effectively.
Working with Sacred Leaf LLC has allowed us access to a fully functional extraction and refinement facility while we undertake the task of retrofitting and permitting our expanded in house lab facility. This arrangement also gives us a brick and mortar retail location at which we can soft-release our products and receive valuable consumer feedback. Furthermore, Sacred Leaf has opened the door for us to several new product distribution channels.
This doesn’t include any of the other acquisitions we just recently did FYI! READ between the lines!
Our partnership has provided Sacred Leaf with an exponentially less expensive source of alkaloids for their delicious mocktails, as well as tinctures and gummies. Check out their website and products at https://www.sacredleaf.com/
As a registered provider through the Novus Cannabis MedPlan our products are offered and co-marketed to a network of over 5000 subscribers. Patients will soon be able to receive insurance benefits and discounts on our products at over 300 dispensaries nationwide. Explore their network at https://getnovusnow.com/
Again $BLEG is real deal and wanted you all to just see what one of our subsidiaries is capable of doing!!
HUGE!! Insurance benefits.. RECURRING REVENUES is what I READ aloud and clear!!
Anyhow, just wanted to share a little DD from their investor presentation just for one of our subsidiaries!
HUGELY UNDERVALUED in my opinion!
Not financial advise just STOKED what AMAZING company we have!
18 pages and these are just few tid bits !
$BLEG
BLEG
Respectfully,
Maverick
Recent BLEG News
- Branded Legacy, Inc. Reports Significant Net Income of Over $3.8 Million • InvestorsHub NewsWire • 04/16/2024 12:30:00 PM
- Branded Legacy, Inc. To Add $320,000 In Revenue With New White Label Contract • InvestorsHub NewsWire • 04/09/2024 12:30:00 PM
- Branded Legacy, Inc Announces White Label Deal with Kava & Hobbs, LLC for Kava Vape formulation • InvestorsHub NewsWire • 04/04/2024 12:30:00 PM
- Branded Legacy, Inc. Significantly Expands Asset Portfolio and Production Capacity Through Successful Acquisition of Sycamore BioPharma, Inc. • InvestorsHub NewsWire • 03/12/2024 01:54:43 PM
- Shares of this Biotech Holdings Company Up on LOI • AllPennyStocks.com • 02/29/2024 06:10:00 PM
- Branded Legacy, Inc. Strengthens Position in BioTech Industry with Letter of Intent to Purchase Sycamore BioPharma, LLC • InvestorsHub NewsWire • 02/29/2024 01:30:00 PM
- Branded Legacy, Inc. Expands Operations with Move to State of the Art Biotech Facility in Melbourne, FL • InvestorsHub NewsWire • 02/08/2024 01:30:00 PM
- Branded Legacy, Inc. Innovates with Launch of the First 100% Clear Kava-Based Vaping Product on the Market • InvestorsHub NewsWire • 02/06/2024 02:30:00 PM
- Branded Legacy, Inc. Unveils Major Equipment Acquisition Raising Total Assets to $3,787,215.00 • InvestorsHub NewsWire • 01/30/2024 02:25:00 PM
- Branded Legacy, Inc. Reduces Debt by 1.5 Million • InvestorsHub NewsWire • 01/25/2024 01:30:00 PM
- Branded Legacy, Inc. ($BLEG) Announces Reduction in Authorized Share Count to 900M • InvestorsHub NewsWire • 01/23/2024 01:30:00 PM
- Branded Legacy, Inc. (BLEG) Expands Portfolio with Comprehensive Acquisition of MariJ Pharmaceuticals Inc, Including Licenses, Organic Certifications, and Substantial Assets • InvestorsHub NewsWire • 12/05/2023 01:00:00 PM
- Branded Legacy Commences Buyback of 1,000,000 Preferred Class D Shares • InvestorsHub NewsWire • 11/28/2023 12:23:33 PM
- Branded Legacy Signs Letter of Intent to Acquire $6 Million in Assets and Additional Facility Space • InvestorsHub NewsWire • 11/16/2023 12:00:00 PM
- Branded Legacy, Inc. Announces 1.5B Reduction in Authorized Share Count • InvestorsHub NewsWire • 11/09/2023 12:03:15 PM
- Branded Legacy, Inc. Secures $1M Line of Credit, Affirms No Reverse Split, and Previews Upcoming Investor Engagements • InvestorsHub NewsWire • 11/07/2023 12:02:43 PM
- Branded Legacy Takes Bold Step in Strengthening Shareholder Value: Retires 1 Billion Common Shares This Week, With More to Follow • InvestorsHub NewsWire • 10/26/2023 12:30:00 PM
- Rocket Web Development & Design: Navigating the Digital Frontier with Innovation and Excellence • InvestorsHub NewsWire • 10/24/2023 01:00:00 PM
- Branded Legacy, Inc. Has Retired 600 Million Common Shares on Path to Retire 2 Billion by November 2023 • InvestorsHub NewsWire • 10/19/2023 12:00:00 PM
- Branded Legacy Completes Acquisition of The Alcannabist, Signifying Business Expansion • InvestorsHub NewsWire • 10/10/2023 12:25:00 PM
- Total Refinement Solutions LLC Transitions to Royal Biotek Under $BLEG Portfolio • InvestorsHub NewsWire • 10/05/2023 12:18:33 PM
- Branded Legacy Expands Facility to 11,000 Sqft, Extends LOI for Acquisition of The Alcannabist LLC • InvestorsHub NewsWire • 10/03/2023 12:00:00 PM
- Branded Legacy Inc. Unveils Exciting Q4 2023 Milestones and Forges Ahead with Key Partnerships • InvestorsHub NewsWire • 09/28/2023 02:44:40 PM
- Branded Legacy Inc. Invests Heavily in Innovation and Growth with $540,000 Expansion • InvestorsHub NewsWire • 09/26/2023 02:37:45 PM
- Branded Legacy and Novus Partner to Develop Plant-Based Meds for Health Plans • InvestorsHub NewsWire • 09/12/2023 11:30:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM
Avant Technologies to Implement AI-Empowered, Zero Trust Architecture in Its Data Centers • AVAI • Apr 29, 2024 8:00 AM
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • BLO • Apr 25, 2024 8:52 AM